newsfilter
← Latest News
GlobeNewswire·

Nkarta to Participate in Evercore Healthcare Conference

  • Nkarta, Inc. (NASDAQ: NKTX) announced its participation in the Evercore 8th Annual Healthcare Conference.
  • The fireside chat is scheduled for Thursday, December 4, 2025, at 10:50 a.m. ET in Miami.
  • A simultaneous webcast of the event will be available on the Investors section of Nkarta's website.
  • A replay of the presentation will be archived on the company website for approximately 90 days.
  • Nkarta is a clinical-stage biotechnology company developing allogeneic, off-the-shelf natural killer (NK) cell therapies for autoimmune diseases.
  • The company utilizes a cell expansion & cryopreservation platform combined with proprietary cell engineering technologies.
  • Nkarta is building a pipeline of future cell therapies intended for deep therapeutic activity & broad access in outpatient treatment settings.
  • Nadir Mahmood serves as the media & investor contact for Nkarta.